Halda Raises $126m For First Clinical Trial Of Its RIPTAC Modality

Heterobifunctional Molecules From A PROTAC Pioneer

 
• By Mandy Jackson
Venture capital. Long term business investment
Halda has raised $202m to date • Source: Shutterstock

More from Financing

More from Business